These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease. Quaschning T; Krane V; Metzger T; Wanner C Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915 [TBL] [Abstract][Full Text] [Related]
3. [Lipid metabolism abnormalities and atherosclerosis in patients on maintenance hemodialysis]. Musiał J; Undas A; Sysło K Przegl Lek; 1994; 51(6):264-7. PubMed ID: 7938663 [TBL] [Abstract][Full Text] [Related]
4. Atherogenic lipoproteins in end-stage renal disease. Shoji T; Ishimura E; Inaba M; Tabata T; Nishizawa Y Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S30-3. PubMed ID: 11576918 [TBL] [Abstract][Full Text] [Related]
5. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease. Vaziri ND J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569 [TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia and renal disease: pathogenesis and clinical consequences. Wanner C; Quaschning T Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):195-201. PubMed ID: 11224694 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in chronic renal failure. Hasselwander O; Young IS Free Radic Res; 1998 Jul; 29(1):1-11. PubMed ID: 9733016 [TBL] [Abstract][Full Text] [Related]
8. Treatment of dyslipidemia in chronic kidney disease. Stefanovic V; Milojkovic M Int J Artif Organs; 2004 Oct; 27(10):821-7. PubMed ID: 15560675 [TBL] [Abstract][Full Text] [Related]
9. Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure. Hasselwander O; Young IS Med Hypotheses; 1997 Nov; 49(5):389-95. PubMed ID: 9421803 [TBL] [Abstract][Full Text] [Related]
10. Optimal management of combined dyslipidemia: what have we behind statins monotherapy? Tenenbaum A; Fisman EZ; Motro M; Adler Y Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960 [TBL] [Abstract][Full Text] [Related]
16. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors]. Boizel R Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Siems W; Quast S; Carluccio F; Wiswedel I; Hirsch D; Augustin W; Hampi H; Riehle M; Sommerburg O Clin Nephrol; 2002 Jul; 58 Suppl 1():S12-9. PubMed ID: 12227720 [TBL] [Abstract][Full Text] [Related]
18. HDL metabolism and activity in chronic kidney disease. Vaziri ND; Navab M; Fogelman AM Nat Rev Nephrol; 2010 May; 6(5):287-96. PubMed ID: 20308998 [TBL] [Abstract][Full Text] [Related]